- Wondering if IDEXX Laboratories at around US$657 a share still makes sense for your portfolio, or if the price is getting ahead of itself?
- The stock has seen mixed moves recently, with a 3.5% gain over the last 7 days, a 5.8% decline over the past month, and returns of 43.6% over 1 year and 40.1% over 3 years.
- Investors have been reacting to ongoing updates around the animal diagnostics and pet care market, including continued attention on long term demand for veterinary services and diagnostic testing. These themes often influence how the market prices IDEXX Laboratories relative to other healthcare names.
- Right now, IDEXX Laboratories scores 0 out of 6 on our valuation checks. You can see this in more detail in our valuation…
Crypto leaders warn Australian government: Act or fall behind
February 26, 2026
